Residential College | true |
Status | 已發表Published |
Pharmacological therapies and drug development targeting SARS-CoV-2 infection | |
Yizhou Jiang1; Limor Rubin2; Zheng WH(鄭文華)3![]() | |
2022-12 | |
Source Publication | CYTOKINE & GROWTH FACTOR REVIEWS
![]() |
ISSN | 1359-6101 |
Document Type | Journal article |
Collection | Faculty of Health Sciences |
Corresponding Author | Zheng WH(鄭文華) |
Affiliation | 1.Faculty of Health Science, University of Macau, Taipa, Macau, China 2.Allergy and Clinical Immunology Unit, Department of Medicine, Hadassah-Hebrew University Medical Center, Jerusalem 9112001, Israel. 3.Centre of Reproduction, Development and Aging and Institute of Translation Medicine, Faculty of Health Sciences, University of Macau, Macau 999078, China; Brain Research Centre and Department of Biology, School of Life Science, Southern University of Science and Technology, 1088 Xueyuan Blvd, Nanshan District, Shenzhen, Guangdong Province 518055, China |
First Author Affilication | University of Macau |
Corresponding Author Affilication | Centre of Reproduction, Development and Aging |
Recommended Citation GB/T 7714 | Yizhou Jiang,Limor Rubin,Zheng WH. Pharmacological therapies and drug development targeting SARS-CoV-2 infection[J]. CYTOKINE & GROWTH FACTOR REVIEWS, 2022. |
APA | Yizhou Jiang., Limor Rubin., & Zheng WH (2022). Pharmacological therapies and drug development targeting SARS-CoV-2 infection. CYTOKINE & GROWTH FACTOR REVIEWS. |
MLA | Yizhou Jiang,et al."Pharmacological therapies and drug development targeting SARS-CoV-2 infection".CYTOKINE & GROWTH FACTOR REVIEWS (2022). |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment